Histoplasmosis

Clinics in Chest Medicine

Volumn 30, Issue 2, 2009, Pages 217-225

  Kauffman, Carol A ^a  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Disseminated histoplasmosis; Endemic mycoses; Histoplasma capsulatum; Histoplasmosis; Pulmonary histoplasmosis

Indexed keywords

ADALIMUMAB; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CORTICOSTEROID; ETANERCEPT; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ITRACONAZOLE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; POSACONAZOLE; TUMOR NECROSIS FACTOR INHIBITOR; VORICONAZOLE;

ANTIGEN DETECTION; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG FORMULATION; EPIDEMIC; FIBROSIS; FUNGUS CULTURE; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; LUNG BIOPSY; LUNG INFECTION; MEDIASTINITIS; NEPHROTOXICITY; PERICARDITIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; THORAX RADIOGRAPHY;

HISTOPLASMOSIS; HUMANS;

EID: 64249098442     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2009.02.002     Document Type: Review

References (63)

1. Kauffman C.A. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20 (2007) 115-132
2. Cano M., and Hajjeh R.A. The epidemiology of histoplasmosis: a review. Semin Respir Infect 16 (2001) 109-118
3. Wheat L.J., Wass J., Norton J., et al. Cavitary histoplasmosis occurring during two large urban outbreaks: analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) 63 (1984) 201-209
4. Newman S.L. Cell-mediated immunity to Histoplasma capsulatum. Semin Respir Infect 16 (2001) 102-108
5. Kauffman C.A. Endemic mycoses in patients with hematologic malignancies. Semin Respir Infect 17 (2002) 106-112
6. McKinsey D.S., Spiegel R.A., Hutwagner L., et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 24 (1997) 1195-1203
7. Jones T.F., Swinger G.L., Craig A.S., et al. Acute pulmonary histoplasmosis in bridge workers: a persistent problem. Am J Med 106 (1999) 480-482
8. Odio C.M., Navarrete M., Carrillo J.M., et al. Disseminated histoplasmosis in infants. Pediatr Infect Dis J 18 (1999) 1065-1068
9. Couppie P., Sobesky M., Aznar C., et al. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin Infect Dis 38 (2004) 134-138
10. Assi M.A., Sandid M.S., Baddour L.M., et al. Systemic histoplasmosis. A 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) 86 (2007) 162-169
11. Kauffman C.A. Endemic mycoses after hematopoietic stem cell or solid organ transplantation. In: Bowden R.A., Ljungman P., and Paya C.V. (Eds). Transplant infections. 2nd edition (2003), Lippincott Williams & Wilkins, Philadelphia 524-534
12. Freifeld A.G., Iwen P.C., Lesiak B.L., et al. Histoplasmosis in solid organ transplant recipients at a large midwestern university transplant center. Transpl Infect Dis 7 (2005) 109-115
13. Crum N.F., Lederman E.R., and Wallace M.R. Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore) 84 (2005) 291-302
14. Wood K.L., Hage C.A., Knox K.S., et al. Histoplasmosis after treatment with anti-TNF-(alpha) therapy. Am J Respir Crit Care Med 167 (2003) 1279-1282
15. Lee J.-H., Slifman N.R., Gershon S.K., et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept. Arthritis Rheum 46 (2002) 2565-2570
16. Deepe Jr. G.S. Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-α factor activity. Clin Infect Dis 41 (2005) S204-S207
17. Limaye A.P., Connolly P.A., Sagar M., et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 343 (2000) 1163-1166
18. Wheat L.J., Conces D., Allen S.D., et al. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med 25 (2004) 129-144
19. Gurney J.W., and Conces D.J. Pulmonary histoplasmosis. Radiology 199 (1996) 297-306
20. Goodwin Jr. R.A., Owens F.T., Snell J.D., et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 55 (1976) 413-452
21. Landay M.J., and Rollins N.K. Mediastinal histoplasmosis granuloma: evaluation with CT. Radiology 172 (1989) 657-659
22. Parish J.M., and Rosenow III E.C. Mediastinal granuloma and mediastinal fibrosis. Semin Respir Crit Care Med 23 (2002) 135-143
23. Loyd J.E., Tillman B.F., Atkinson J.B., et al. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 67 (1988) 295-310
24. Davis A., Pierson D., and Loyd J.E. Mediastinal fibrosis. Semin Respir Infect 16 (2001) 119-130
25. Doyle T.P., Loyd J.E., and Robbins I.M. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am J Respir Crit Care Med 164 (2001) 657-660
26. Picardi J.L., Kauffman C.A., Schwarz J., et al. Pericarditis caused by Histoplasma capsulatum. Am J Cardiol 37 (1976) 82-88
27. Wheat L.J., Stein L., Corya B.C., et al. Pericarditis as a manifestation of histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 62 (1983) 110-119
28. Goodwin Jr. R.A., Shapiro J.L., Thurman G.H., et al. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 59 (1980) 1-33
29. Kirn D.H., Fredericks D., McCutchan J.A., et al. Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis. Clin Infect Dis 21 (1995) 1048-1049
30. Rouphael N.G., Talati N.J., Vaughan C., et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 7 (2007) 814-822
31. Masri K., Mahon N., Rosario A., et al. Reactive hemophagocytic syndrome associated with disseminated histoplasmosis in a heart transplant recipient. J Heart Lung Transplant 22 (2003) 487-491
32. Schestatsky P., Chedid M.F., Amaral O.B., et al. Isolated central nervous system histoplasmosis in immunocompetent hosts: a series of 11 cases. Scand J Infect Dis 38 (2006) 43-48
33. Wheat L.J., Musial C.E., and Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 40 (2005) 844-852
34. Wheat L.J. Improvements in diagnosis of histoplasmosis. Expert Opin Biol Ther 6 (2006) 1207-1221
35. Fuller D.D., Davis Jr. T.E., Denys G.A., et al. Evaluation of BACTEC MYCO/F lytic medium for recovery of mycobacteria, fungi, and bacteria from blood. J Clin Microbiol 39 (2001) 2933-2936
36. Wheat L.J. Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis 8 (2006) 128-139
37. Kauffman C.A. Diagnosis of histoplasmosis in immunosuppressed patients. Curr Opin Infect Dis 21 (2008) 421-425
38. Wheat L.J., Connolly-Stringfield P., Kohler R.B., et al. Histoplasma capsulatum polysaccharide antigen detection in the diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 89 (1989) 396-400
39. Wheat L.J., Garringer T., Brizendine E., et al. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn Microbiol Infect Dis 43 (2002) 29-37
40. Connolly P.A., Durkin M.M., LeMonte A.M., et al. Improvement in the detection of Histoplasma antigen by a quantitative immunoassay. Clin Vaccine Immunol 14 (2007) 1587-1591
41. LeMonte A., Egan L., Connolly P., et al. Evaluation of the IMMY ALPHA Histoplasma antigen enzyme immunoassay for diagnosis of histoplasmosis marked by antigenuria. Clin Vaccine Immunol 14 (2007) 802-803
42. Cloud J.L., Bauman S.K., Pelfrey J.M., et al. Biased report on the IMMY ALPHA Histoplasma antigen enzyme immunoassay for diagnosis of histoplasmosis. Clin Vaccine Immunol 14 (2007) 1389-1391
43. Wheat J., Wheat H., Connolly P., et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 24 (1997) 1169-1171
44. Durkin M., Witt J., Lemonte A., et al. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 42 (2004) 4873-4875
45. Wheat L.J., Hackett E., Durkin M., et al. Histoplasmosis-associated cross-reactivity in the BioRad platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol 14 (2007) 638-640
46. Wheat L.J., Connolly-Stringfield P., Williams B., et al. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis 145 (1992) 1421-1424
47. Bialek R., Ernst F., Dietz K., et al. Comparison of staining methods and a nested PCR assay to detect Histoplasma capsulatum in tissue sections. Am J Clin Pathol 117 (2002) 597-603
48. Bracca A., Tosello M.E., Girardini J.E., et al. Molecular detection of Histoplasma capsulatum var capsulatum in human clinical samples. J Clin Microbiol 41 (2003) 1753-1755
49. Wheat L.J., Freifeld A.G., Kleiman M.B., et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 45 (2007) 807-817
50. Dismukes W.E., Bradsher Jr. R.W., Cloud G.C., et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 93 (1992) 489-497
51. Wheat J., Hafner R., Korzun A.H., et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med 98 (1995) 336-342
52. McKinsey D.S., Kauffman C.A., Pappas P.G., et al. Fluconazole therapy for histoplasmosis. Clin Infect Dis 23 (1996) 996-1001
53. Wheat J., Mawhinney S., Hafner R., et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med 103 (1997) 223-232
54. Nath D.S., Kandaswamy R., Gruessner R., et al. Fungal infections in transplant recipients receiving alemtuzumab. Transplant Proc 37 (2005) 934-936
55. Restrepo A., Tobon A., Clark B., et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 54 (2007) 319-327
56. Clark B., Foster R., Tunbridge A., et al. A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole. J Infect 51 (2005) e177-e180
57. Pitisuttithum P., Negroni R., Graybill J.R., et al. Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 56 (2005) 745-755
58. Wheat L.J., Connolly P., Smedema M., et al. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. J Antimicrob Chemother 57 (2006) 1235-1239
59. Johnson P.C., Wheat L.J., Cloud G.A., et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 137 (2002) 105-109
60. Wheat L.J., Cloud G., Johnson P.C., et al. Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrobial Agents Chemother 45 (2001) 2354-2357
61. Lenhart SW, Schafer MP, Singal M, et al. Histoplasmosis: protecting workers at risk. DHHS (NIOSH) Publication No. 97-146, 1997.
62. McKinsey D.S., Wheat L.J., Cloud G.A., et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. Clin Infect Dis 28 (1999) 1049-1056
63. Vail G.M., Young R.S., Wheat L.J., et al. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 4 (2002) 148-151